Elevated CD4+ and CD4+FOXP3+ populations were correlated with shorter recurrence-free survival, and the perivascular CD4+FOXP3+ Treg population in primary tumors was identified as an independent predictor of tumor recurrence in this cohort [17]. This evidence concerns the gene FOXP3 and neoplasm.